KALAKala Pharmaceuticals
About Kala Pharmaceuticals
Kala Pharmaceuticals (NASDAQ:KALA) specializes in developing innovative eye care treatments, particularly focusing on therapies for diseases with significant unmet medical needs. The company works on a range of projects, from early research to advanced clinical trials, aiming to bring groundbreaking solutions to patients suffering from eye conditions worldwide. Key objectives include advancing its pipeline of drug candidates through rigorous testing, securing regulatory approvals, and ultimately improving patient outcomes. With a strong commitment to eye health, Kala Pharmaceuticals is dedicated to making strides in ophthalmic treatment and care.
What is KALA known for?
Snapshot
Public US
Ownership
2009
Year founded
43
Employees
Watertown, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...
Operations
All Locations
United States
Products and/or services of Kala Pharmaceuticals
- EYSUVIS, a corticosteroid for the short-term treatment of the signs and symptoms of dry eye disease.
- Pipeline focusing on novel treatments for eye diseases using proprietary mucus-penetrating particle (MPP) technology.
- Research on advanced formulations for challenging ocular conditions, aiming to enhance drug delivery and efficacy.
- Clinical trials aimed at expanding applications of their technology in ocular disease treatment.
- Partnerships for the development and distribution of eye care products and technologies.
Kala Pharmaceuticals executive team
- Dr. R. Kim Brazzell Ph.D.Head of R&D and Chief Medical Officer
- Mr. Todd BazemorePrincipal Executive Officer & Director
- Mr. David Elliot LazarCEO, CFO, President, COO & Chair of the Board
- Dr. Justin Hanes Ph.D.Founder & Chair of the Scientific Advisory Board
- Ms. Jill S. SteierExecutive Director of Investor Relations & Corporate Communications
- Mr. Vincent KosewskiSenior VP of Manufacturing & Supply Chain Management
- Mr. Darius Kharabi J.D., M.B.A.Chief Business Officer
- Dr. Francis S. Mah M.D.Chief Medical Advisor
- Ms. Mary Reumuth CPATreasurer & Secretary
- Mr. Josiah CraverSenior VP & Corporate Controller